Credit Opportunities: Managing Shifting Tides

Market Volatility and Recovery (Feb–April):

• The credit market transitioned from a healthy state to a bear market in under 30 days, driven by uncertainty regarding the virus's contagion and policy responses.
• The recovery was accelerated by the Fed's aggressive rate cuts, the CARES Act, and the establishment of primary and secondary credit market facilities.
• High-quality issuers (AA, AA+, A) accessed capital markets at wide spreads (e.g., 225-310 bps over swaps), presenting immediate opportunities.
• Long-dated investment-grade credit returned over 11% in Q2, outperforming the high-yield sector during the stabilization phase.

Private Credit Market Dynamics:

• Private markets emerged as a critical alternative for mid-market and non-eligible borrowers excluded from public capital markets due to the "QSIB" (Qualified Senior Investment Grade Borrower) nature of central bank purchases.
• Private credit saw increased deployment of "dry powder," with some asset managers providing billion-dollar financing packages, validating the asset class as a legitimate alternative to bank lending.
• The sector is shifting toward bespoke, tailor-made structures (including preferred equity and mezzanine debt) to recapitalize struggling companies, distinguishing it from the "one-size-fits-all" public markets.
• Concerns exist regarding "front-running" central bank signals, which may distort price discovery and asset selection merit if money becomes effectively valueless.

Sector-Specific Performance and Risks:

• Stress Sectors: Transportation, restaurants, and energy face severe liquidity stress; airlines are burning $25–50 million daily despite government support.
• Outperforming Sectors: Consumer non-cyclicals, healthcare, communications, and software (driven by subscription models) demonstrated resilience and record performance.
• CLOs: Collateralized Loan Obligations (CLOs) performed well with only $40 billion in defaults year-to-date compared to $120 billion in 2008–2009, benefiting from 10-year locked-up financing to buy assets during volatility.
• High Yield/Leveraged Loans: Yields have compressed to below 6%, reducing risk-adjusted returns and creating a "truffle hunt" environment where value is harder to find.

Corporate Fundamentals and "Zombie" Companies:

• A divergence exists between stretched fundamentals (negative Q2 GDP, high leverage) and valuations; however, stressed sectors have accessed secured financing to extend their "runway" until economic reopening.
• There is a growing risk of "zombie companies" (over-levered, inefficient entities) being kept afloat by cheap credit rather than market forces, particularly in sectors with permanently disrupted business models (e.g., retail, energy).
• S&P predicts approximately $330 billion more in downgrades from investment grade to "fallen angels" year-to-date, excluding B-rated to CCC-rated downgrades.
• Default rates have risen 7% year-to-date, with expectations of reaching double-digit levels in the near future, particularly for C-rated borrowers unable to access capital markets.

Central Bank Policy and Macroeconomic Outlook:

• The Fed's shift to "average inflation targeting" and willingness to let inflation run hot have effectively removed the "left tail" (disaster risk) from credit strategies, acting as a put option for investors.
• The Fed has deployed less capital than signaled, leaving room for further intervention if a second or third wave of the virus causes significant market pullbacks.
• Monetary policy is propping up financial asset prices, but Anne Walsh notes that debt is deflationary until it moves into productive capacity, raising questions about future inflation triggers.
• Private capital flows are expected to become more selective and discriminating over time, potentially weeding out zombie companies and favoring true winners in the next cycle.

Future Outlook and Scenarios:

• A return to distressed cycles is unlikely in the immediate 1–2 years due to aggressive central bank and fiscal support, but excesses will eventually build over the next 10–15 years.
• Positive outcomes rely on the arrival of effective therapeutics/protocols, a smooth political transition (election), and a seamless transition away from LIBOR.
• The panel anticipates a healthy surge in GDP and latent demand post-vaccine/distribution, supported by conservative corporate balance sheets and continued policy accommodation.
• Consumer resilience is expected to remain high due to fiscal transfer payments and buoyant stock markets, though unemployment-related payment risks remain a concern for specific segments.

Forward-Looking Statements and Strategic Advice:

• Michael Buchanan: Predicts a "reasonably well" ending due to policy support, corporate conservatism, and the eventual vaccine rollout; investable opportunities exist in distressed but viable sectors.
• Anne Walsh: Identifies therapeutic acceptance and protocols as the primary catalyst to turn the economic cycle, while warning of inflation risks from prolonged money supply expansion.
• Don Young: Forecasts continued opportunities in structured credit (CLOs) yielding double digits for BB-rated mezzanine or CLO equity, provided managers conduct deep-dive analysis to identify survivors.
• Mathieu Chabron: Sees private markets as the future differentiator through bespoke capital solutions, though capital will eventually become more selective, ending the era of indiscriminate zombie support.